Incomplete Voiding (Urinary Retention) - Treatment Overview

1. Immediate management (acute retention)

• Catheterization is first-line - decompress the bladder promptly to relieve pain and prevent bladder/renal injury.
  • Urethral catheter (preferred initially) or suprapubic tube if urethral access fails.
  • Prophylactic catheterization is recommended for surgeries expected to last ≥3 hours or with large fluid volumes, since postoperative retention occurs in 5-70% of cases depending on risk factors (age >50, male sex, pelvic/anorectal/hernia surgery, prior BPH, neurologic disease, neuraxial anesthesia, anticholinergics) - Bailey & Love's Short Practice of Surgery, p. 5528.

2. Chronic/ongoing bladder emptying failure

• Clean Intermittent Catheterization (CIC) is the recommended first-choice long-term strategy for patients who cannot empty the bladder spontaneously and have adequate dexterity (or a caregiver). It reduces long-term complications (hydronephrosis, stones, autonomic dysreflexia) compared with an indwelling catheter - Smith & Tanagho's General Urology, p. 4137.
• Indwelling catheters (urethral or suprapubic) are reserved for patients unable to perform CIC.
• Note: reflex voiding via external (Credé/Valsalva) bladder compression is not recommended - it generates high intradetrusor pressures and risks upper tract damage.

3. Pharmacologic treatment

• Bethanechol (a muscarinic/M3 agonist) can be used for non-obstructive retention - e.g., postoperative or postpartum atonic bladder, or some neurogenic bladders - to stimulate detrusor contraction as an alternative to chronic catheterization. It is ineffective (and inappropriate) if the retention is due to mechanical outlet obstruction - Goodman & Gilman's/Campbell-Walsh Urology.
• Alpha-blockers (tamsulosin, alfuzosin, etc.) and 5-alpha-reductase inhibitors are used when retention is due to bladder outlet obstruction from BPH.
• Address the underlying cause specifically: treat UTI, stop/adjust offending drugs (anticholinergics, opioids, alpha-agonists, sedatives), manage constipation, treat diabetic autonomic neuropathy, etc.

4. Behavioral/non-pharmacologic measures

• Timed voiding and double voiding (waiting briefly after voiding, then trying again) to help ensure complete emptying (NIDDK).
• Pelvic floor physical therapy / biofeedback - especially useful when incomplete emptying is due to pelvic floor muscle tightness/dysfunction (dysfunctional voiding) rather than true detrusor failure.
• Postural adjustments (fully sitting rather than hovering) to allow pelvic floor relaxation.

5. Refractory cases / neurogenic voiding dysfunction

• Sacral neuromodulation (SNM) and percutaneous tibial nerve stimulation (PTNS) are third-line options, increasingly used even in neurogenic populations (stroke, Parkinson's, MS, incomplete spinal cord injury), with 50-80% success rates in select studies - Smith & Tanagho's General Urology, p. 4127.
• Botulinum toxin is generally used for overactive bladder/detrusor overactivity, not for retention - it can actually cause retention as a side effect (relevant caution).

6. Surgical options (when obstruction is structural)

• Urethral dilation, urethral stents, or surgery (e.g., TURP for BPH, stricture repair) when a fixed anatomic obstruction is the cause.

Recent evidence worth flagging

• A 2025 systematic review/meta-analysis found acupuncture may reduce postoperative urinary retention after cervical cancer surgery, though evidence quality is limited (PMID: 39993070).
• A 2024 meta-analysis suggested electroacupuncture may benefit urinary retention outcomes, again with methodological caveats (PMID: 38847671).
• A 2025 narrative systematic review highlighted significant inconsistency in how "urinary retention" is even defined across botulinum toxin studies for overactive bladder, which affects how retention risk/benefit is reported in the literature (PMID: 39960111).